{"name": "Nanotherapeutics",
 "permalink": "nanotherapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/nanotherapeutics",
 "homepage_url": "http://www.nanotherapeutics.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": null,
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "",
 "created_at": "Sat Jan 16 11:19:22 UTC 2010",
 "updated_at": "Sat Jan 16 11:22:20 UTC 2010",
 "overview": "\u003Cp\u003ENanotherapeutics is a privately held specialty biopharmaceutical company with full product development, cGMP manufacturing capabilities, and a proprietary pipeline. The Company\u0026#8217;s technologies can be used with all drug types ranging from small molecules to proteins and peptides. These technologies can be employed with new chemical entities or with generic drugs and can be used with the spectrum of existing drug types ranging from small synthetic molecules to large recombinant macromolecules.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       24],
      "assets/images/resized/0007/3705/73705v2-max-150x150.jpg"],
     [[250,
       40],
      "assets/images/resized/0007/3705/73705v2-max-250x250.jpg"],
     [[300,
       49],
      "assets/images/resized/0007/3705/73705v2-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [],
 "milestones":
  [{"description": "Nanotherapeutics Acquires Two Late Stage Clinical Programs for Alzheimer\u00e2\u20ac\u2122s Treatment and CDA\r\nDisease",
    "stoned_year": 2009,
    "stoned_month": 12,
    "stoned_day": 16,
    "source_url": "http://www.nanotherapeutics.com/news/pdf/Nanotherapeutics_Acquires_Late_Stage_Clinical_Programs_pr12-16-09.pdf",
    "source_text": "",
    "source_description": "Nanotherapeutics Acquires Two Late Stage Clinical Programs for Alzheimer\u00e2\u20ac\u2122s Treatment and CDA Disease",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Nanotherapeutics",
      "permalink": "nanotherapeutics"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}